KL-50: A Novel Therapeutic Agent Targeting MGMT-Deficient Glioblastoma

Journal Article Accepted manuscript KL-50: A Novel Therapeutic Agent Targeting MGMT-Deficient Glioblastoma Get access Kenan Zhang, Kenan Zhang Duke University Medical Center, Duke University, Durham, NC, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Mehdi Touat, Mehdi Touat Neurooncology Departement, Pitié-Salpétrière Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France https://orcid.org/0000-0002-5910-7799 Search for other works by this author on: Oxford Academic PubMed Google Scholar Mustafa Khasraw Mustafa Khasraw Duke University Medical Center, Duke University, Durham, NC, USA Corresponding author: Mustafa Khasraw MD, Duke University Medical Center, Duke University, Box 3624, Durham, NC 27710, USA, Phone: +1 919.684.6173, Email: [email protected] https://orcid.org/0000-0003-3249-9849 Search for other works by this author on: Oxford Academic PubMed Google Scholar Neuro-Oncology, noaf001, https://doi.org/10.1093/neuonc/noaf001 Published: 08 January 2025 Article history Received: 17 December 2024 Published: 08 January 2025